The EWH derived from pepsin and peptidase-mediated hydrolysis had the highest potential against disorders associated with MetS such as hypertension, obesity and T2D, presenting IC50 against DPP-IV of <10 mg protein/mL and against ACE ranging from 47 to 151 μg/mL [19]. Here, DPP4 is linked to type 2 diabetes mellitus.